We invite Stanford researchers across all disciplines to submit interdisciplinary research proposals on learning differences and/or the future of special education for projects funded up to $80,000 for a one year project.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The Center for Artificial Intelligence in Medicine and Imaging (AIMI) and the Institute for Human-Centered Artificial Intelligence (HAI) jointly seek proposals that support new ideas that reimagine artificial intelligence in healthcare.
The goal of the Institute for Human-Centered Artificial Intelligence research program is to foster interdisciplinary AI research that aims to improve the human condition. We seek proposals for up to $75K that support new ambitious ideas.
IMA is accepting proposals for assay development projects to create and optimize miniaturized assays in 384-well microplate format for use in high-throughput, small-molecule screens.
ChEM-H seeks to support research projects driven by junior investigators and aimed at testing molecular hypotheses in human subjects. Submissions must include an MD or MD/PhD investigator and a junior investigator.
The Innovative Medicines Accelerator (IMA) aims to accelerate the translation of scientific discoveries at into new therapeutics that impact human health. This RFP supports treatments for spinal muscular atrophy and other neuromuscular diseases.
The KL2 Mentored Career Development Program (KL2 Scholars Program) at Stanford University is a two-year research program funded by the National Institutes of Health (NIH) and the Stanford Clinical Translational Science Award (CTSA) Program.
Addressing the impact of structural racism and social injustice as key drivers in health disparities that affect maternal and child health are critical to advancing research.
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford Clinical and Translational Research Unit.
